×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Nephrectomy Market Trends

ID: MRFR/MED/3913-CR
110 Pages
Kinjoll Dey
December 2019

Nephrectomy Market Research Report Information by Procedure (Open Nephrectomy, Laparoscopic nephrectomy, Robot-assisted Laparoscopic Surgery), Indication (Kidney Cancer and Kidney Disease), End User (Hospitals & Clinics, Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Nephrectomy Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Nephrectomy Market

Kidney cancer is a sickness where the good cells in one or both kidneys start growing out of control and form lumps, which are called tumors. Chronic kidney disease (CKD), also known as chronic renal disease, chronic renal failure, or chronic kidney failure, is a long-term problem related to the kidneys. It leads to a slow and steady loss of kidney function over time, eventually causing permanent kidney failure. The main reasons for kidney diseases are diabetes and high blood pressure.

To give you an idea of how serious this is, the National Kidney Foundation, Inc. said that CKD is one of the main reasons people die in the US. They found that about 75% of kidney failure cases between 2014 and 2016 were because of diabetes and high blood pressure. According to the World Health Organization's 2018 information, a whopping 422 million people worldwide had diabetes in 2014. The rising number of people with diabetes is causing more kidney problems, and this is pushing forward the nephrectomy market.

Looking at the numbers, the American Cancer Society, Inc. predicted that around 73,820 new cases of kidney cancer would likely happen in the US in 2019. As more people are dealing with issues like diabetes, high blood pressure, and chronic kidney disease, the market for treatments like nephrectomy is growing to help those in need.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

At what CAGR is the nephrectomy market projected to grow in the forecast period (2023-2032)?

Nephrectomy market is projected grow at approximately 4.2% CAGR during the assessment period (2023-2032).

What was the value of the nephrectomy market in 2032?

The valuation of the nephrectomy market had reached USD 5.71 Billion in 2032.

Which is the major segment in the nephrectomy market?

The corticosteroid lotions segment by treatment type holds the majority shares in the nephrectomy market.

Which region holds the largest share in the nephrectomy market?

North America holds the largest share in the nephrectomy market, followed by Europe and the Asia Pacific, respectively.

Who are the top players in the nephrectomy market?

Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany)., Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), B. Braun Melsungen AG (Germany), Cook Group (US), XCELLANCE Medical Technologies (India), and CONMED Corporation (US), are some of the major players operating in the global nephrectomy market.

Which region holds the latest share in the Nephrectomy Market?

North America holds the largest share in the Nephrectomy Market, which is followed by Europe and the Asia Pacific respectively.

Market Summary

As per MRFR analysis, the Nephrectomy Market Size was estimated at 3315.7 USD Million in 2024. The Nephrectomy industry is projected to grow from 3598.72 USD Million in 2025 to 7295.26 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.39 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Nephrectomy Market is experiencing a transformative shift towards advanced surgical techniques and increased patient awareness.

  • Minimally invasive techniques are becoming the preferred choice in nephrectomy procedures, particularly in North America.
  • Technological integration, especially in robotic-assisted nephrectomy, is driving rapid growth in the Asia-Pacific region.
  • Rising awareness of kidney health is influencing patient decisions, leading to increased demand for nephrectomy procedures.
  • The increasing incidence of kidney diseases and advancements in surgical techniques are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 3315.7 (USD Million)
2035 Market Size 7295.26 (USD Million)
CAGR (2025 - 2035) 7.39%
Largest Regional Market Share in 2024 North America

Major Players

<p>Medtronic (US), Johnson & Johnson (US), Baxter International (US), Boston Scientific (US), Stryker (US), Terumo Corporation (JP), Fresenius Medical Care (DE), Smith & Nephew (GB), Cook Medical (US)</p>

Market Trends

The Nephrectomy Market is currently experiencing a notable evolution, driven by advancements in surgical techniques and an increasing prevalence of kidney-related disorders. As healthcare systems worldwide continue to prioritize minimally invasive procedures, the demand for nephrectomy is likely to rise. This shift towards laparoscopic and robotic-assisted surgeries appears to enhance patient recovery times and reduce complications, thereby making these options more appealing to both patients and healthcare providers. Furthermore, the integration of innovative technologies, such as imaging and navigation systems, seems to facilitate more precise surgical interventions, potentially improving overall outcomes. In addition to technological advancements, the Nephrectomy Market is influenced by a growing awareness of kidney health and the importance of early diagnosis. Educational initiatives and public health campaigns may contribute to increased screening and early intervention, which could lead to a higher number of nephrectomy procedures. Moreover, the aging population is likely to further drive demand, as older individuals are more susceptible to kidney diseases. Overall, the Nephrectomy Market appears poised for growth, with various factors converging to shape its future trajectory.

Minimally Invasive Techniques

The trend towards minimally invasive surgical techniques is reshaping the Nephrectomy Market. Laparoscopic and robotic-assisted surgeries are gaining traction due to their potential to reduce recovery times and minimize postoperative complications. This shift not only enhances patient satisfaction but also encourages healthcare providers to adopt these advanced methods.

Technological Integration

The integration of cutting-edge technologies into nephrectomy procedures is becoming increasingly prevalent. Innovations such as advanced imaging systems and surgical navigation tools are likely to improve precision during operations. This technological evolution may lead to better surgical outcomes and increased safety for patients undergoing nephrectomy.

Rising Awareness of Kidney Health

There is a growing emphasis on kidney health awareness, which is influencing the Nephrectomy Market. Public health campaigns and educational initiatives are likely to promote early detection and intervention for kidney diseases. This heightened awareness may result in an increase in nephrectomy procedures as more individuals seek treatment for kidney-related issues.

Nephrectomy Market Market Drivers

Increasing Healthcare Expenditure

Rising healthcare expenditure across various regions is positively impacting the Global Nephrectomy Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to improved access to surgical procedures, including nephrectomy. Enhanced funding allows for better facilities, advanced technologies, and skilled healthcare professionals, which collectively contribute to higher surgical volumes. As healthcare spending continues to grow, the market is poised for expansion, aligning with the overall trends in healthcare investment and patient care.

Rising Incidence of Kidney Diseases

The increasing prevalence of kidney diseases globally is a primary driver of the Global Nephrectomy Market Industry. Conditions such as chronic kidney disease and renal cell carcinoma are on the rise, necessitating surgical interventions like nephrectomy. According to health statistics, the incidence of kidney cancer has been steadily increasing, with projections indicating that by 2024, the market could reach 3.46 USD Billion. This growing patient population underscores the need for effective surgical solutions, thereby propelling the demand for nephrectomy procedures and related technologies.

Growing Awareness and Screening Programs

Increased awareness regarding kidney health and the importance of early detection is contributing to the growth of the Global Nephrectomy Market Industry. Public health initiatives and screening programs aimed at identifying kidney diseases at earlier stages are becoming more prevalent. These efforts are likely to lead to higher rates of diagnosis and, consequently, a greater number of nephrectomy procedures. As healthcare systems worldwide prioritize preventive measures, the market is expected to expand, aligning with the projected CAGR of 5.85% from 2025 to 2035, indicating a robust growth trajectory.

Aging Population and Associated Health Issues

The aging population is a significant factor driving the Global Nephrectomy Market Industry. As individuals age, the risk of developing kidney-related ailments increases, leading to a higher demand for nephrectomy procedures. The demographic shift towards an older population is evident globally, with projections indicating that by 2035, a substantial portion of the population will be over 65 years old. This demographic trend is likely to result in an increased incidence of kidney diseases, thereby fueling the demand for nephrectomy and related healthcare services.

Technological Advancements in Surgical Techniques

Innovations in surgical techniques and technologies are significantly influencing the Global Nephrectomy Market Industry. Minimally invasive procedures, such as laparoscopic nephrectomy, have gained traction due to their benefits, including reduced recovery times and lower complication rates. These advancements not only enhance surgical outcomes but also attract more patients seeking nephrectomy. As the industry evolves, the integration of robotic-assisted surgeries is expected to further drive market growth. The anticipated market size of 6.46 USD Billion by 2035 reflects the impact of these technological improvements on surgical practices.

Market Segment Insights

By Procedure Type: Laparoscopic Nephrectomy (Largest) vs. Robotic-Assisted Nephrectomy (Fastest-Growing)

<p>In the Nephrectomy Market, Laparoscopic Nephrectomy has emerged as the largest segment, highlighting its widespread acceptance due to minimally invasive techniques that offer patients quicker recovery times and reduced hospital stays. Open Nephrectomy, while still significant, has seen a decline in preference as advancements in laparoscopic methods gain traction. Partial Nephrectomy is also gaining attention as a solution for renal preservation, though it holds a smaller overall market share compared to its counterparts. The growth trends in the Nephrectomy Market are driven by technological innovations and increased awareness among patients regarding treatment options. Robotic-Assisted Nephrectomy is quickly becoming the fastest-growing segment, as surgeons and hospitals adopt robotic systems to enhance precision and reduce complications. Additionally, the rise in kidney-related ailments along with a focus on minimally invasive procedures is further propelling the market, creating a competitive landscape for both laparoscopic and robotic procedures.</p>

<p>Laparoscopic Nephrectomy (Dominant) vs. Robotic-Assisted Nephrectomy (Emerging)</p>

<p>Laparoscopic Nephrectomy is currently the dominant procedure in the Nephrectomy Market, favored for its reduced recovery times, minimally invasive nature, and lower complication rates. Surgeons are increasingly trained in laparoscopic techniques, contributing to its popularity. In contrast, Robotic-Assisted Nephrectomy is an emerging procedure, gaining momentum for its ability to enhance surgical precision and improve outcomes. Despite being newer, it benefits from advanced robotics and growing surgeon experience, positioning it for future growth. As hospitals continue to invest in robotic surgical systems, the gap between laparoscopic and robotic-assisted methods may narrow, leading to a transformation in standard nephrectomy practices.</p>

By Indication: Renal Cell Carcinoma (Largest) vs. Kidney Stones (Fastest-Growing)

<p>In the Nephrectomy Market, Renal Cell Carcinoma (RCC) represents the largest segment, significantly dominating the indications for surgical procedures. This is due to increasing incidences of RCC and advancements in diagnostic techniques leading to earlier detection, which in turn boosts the demand for nephrectomy. Kidney Stones is emerging as a fast-growing segment owing to rising prevalence attributed to dietary changes and lifestyle factors impacting kidney health. This growth trend indicates a shifting focus toward addressing this common yet significant urological condition.</p>

<p>RCC (Dominant) vs. Kidney Stones (Emerging)</p>

<p>Renal Cell Carcinoma (RCC) is regarded as the dominant indication in the nephrectomy market, characterized by its aggressive nature and increasing rates of diagnosis. The preference for renal procedures in the management of RCC is attributed to its effectiveness in controlling advanced disease and improving survival rates. On the other hand, Kidney Stones are gaining traction as an emerging segment, driven by both high incidence rates and increased awareness surrounding prevention and treatment options. The evolving treatment modalities for kidney stones, including minimally invasive procedures, are shifting market dynamics, attracting a diverse patient demographic seeking effective management.</p>

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

<p>In the Nephrectomy Market, hospitals represent the largest share in the end-user segment, accounting for a significant portion of the procedures conducted. Their comprehensive infrastructure and availability of specialized equipment and skilled professionals contribute to their dominance. In contrast, Ambulatory Surgical Centers (ASCs) are gaining traction, appealing to patients seeking less invasive options and shorter recovery times, thereby capturing a growing market share.</p>

<p>Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)</p>

<p>Hospitals play a pivotal role in the Nephrectomy Market due to their established facilities and diverse offering of surgical interventions. They are equipped with advanced technology and multidisciplinary teams that ensure comprehensive patient care, making them the preferred choice for complex nephrectomy procedures. On the other hand, Ambulatory Surgical Centers are emerging as a viable alternative, providing patients with cost-effective and convenient options for kidney surgeries. These centers are designed for efficiency, catering to minimally invasive procedures and enabling shorter hospital stays, thus appealing to a growing segment of patients aiming for rapid recovery.</p>

By Surgical Approach: Minimally Invasive Surgery (Largest) vs. Traditional Surgery (Fastest-Growing)

<p>In the Nephrectomy Market, the surgical approaches are categorized into minimally invasive surgery, traditional surgery, and transplant surgery. Of these, minimally invasive surgery holds the largest market share due to its advantages such as reduced recovery time, less postoperative pain, and shorter hospital stays. Traditional surgery, while still significant, is gradually losing ground to more advanced surgical techniques that offer better patient outcomes and quicker recovery periods. Transplant surgery, although essential, comprises a smaller portion of the market but is critical for patients with renal failure.</p>

<p>Minimally Invasive Surgery (Dominant) vs. Traditional Surgery (Emerging)</p>

<p>Minimally invasive surgery is the dominant approach in the Nephrectomy Market, characterized by techniques such as laparoscopic nephrectomy that reduce incision sizes and minimize trauma. These procedures are paving the way for improved patient satisfaction and lower complication rates, thus becoming the preferred choice among both patients and surgeons. Traditional surgery, while still an important part of nephrectomy, is increasingly being viewed as an option of last resort. This shift is driven by advancements in technology, such as robotic-assisted surgeries and enhanced imaging techniques, leading to a growing acceptance of minimally invasive procedures. Consequently, traditional surgery is seen as an emerging segment in the context of evolving clinical practices.</p>

By Patient Demographics: Adult Patients (Largest) vs. Geriatric Patients (Fastest-Growing)

<p>In the Nephrectomy Market, adult patients represent the largest segment, holding a significant share due to the higher prevalence of kidney-related conditions among this age group. This demographic accounts for the majority of nephrectomy procedures performed globally, largely driven by lifestyle factors, comorbidities, and increasing rates of renal diseases. On the other hand, geriatric patients, while smaller in total population, are rapidly emerging as the fastest-growing demographic in this market. This growth can be attributed to the aging population and the rising incidence of renal disorders within this group, compelling healthcare providers to adapt to their specific needs. The growth trends within the patient demographics for nephrectomy highlights a shift towards addressing the needs of the geriatric population. Advances in surgical techniques and postoperative care are increasingly catering to older patients, leading to improved outcomes and a more significant number of procedures being performed in this demographic. Additionally, as awareness of kidney health grows, older patients are being diagnosed earlier, enhancing treatment opportunities. The adult segment continues to dominate the market, but the geriatric demographic is showing promising growth opportunities for nephrology professionals and healthcare facilities.</p>

<p>Adult Patients (Dominant) vs. Pediatric Patients (Emerging)</p>

<p>The adult patient segment remains dominant in the nephrectomy market, primarily due to the higher prevalence of nephrology-related diseases such as chronic kidney disease (CKD) and kidney cancer. Adults are more likely to undergo nephrectomy procedures as a result of these conditions, with a well-established healthcare framework supporting surgical interventions. Conversely, pediatric patients represent an emerging segment, characterized by unique clinical considerations, including congenital diseases and pediatric-specific renal issues. While this segment is smaller in terms of total procedures, increased awareness and advances in pediatric surgical techniques are slowly propelling its growth. Pediatric nephrectomy is becoming increasingly recognized, leading to greater research, resources, and specialized care focused on this demographic.</p>

Get more detailed insights about Nephrectomy Market Research Report - Forecast till 2035

Regional Insights

North America : Market Leader in Nephrectomy

North America continues to lead the nephrectomy market, holding a significant share of 1656.0 million in 2024. The growth is driven by advanced healthcare infrastructure, increasing prevalence of kidney diseases, and rising awareness about surgical options. Regulatory support and innovation in surgical techniques further enhance market dynamics, making it a hub for nephrectomy procedures. The United States is the primary contributor, with key players like Medtronic, Johnson & Johnson, and Baxter International dominating the landscape. The competitive environment is characterized by continuous advancements in technology and a focus on minimally invasive procedures. This region's robust healthcare policies and investment in research and development solidify its position as a leader in the nephrectomy market.

Europe : Emerging Market with Growth Potential

Europe's nephrectomy market is valued at 1000.0 million, reflecting a growing demand for surgical interventions. Factors such as an aging population, increasing incidence of renal diseases, and advancements in surgical techniques are driving this growth. Regulatory frameworks in various countries are also evolving to support innovative treatment options, enhancing patient access to nephrectomy procedures. Leading countries like Germany, France, and the UK are at the forefront, with a competitive landscape featuring major players such as Fresenius Medical Care and Smith & Nephew. The market is characterized by a mix of established companies and emerging startups, fostering innovation and improving patient outcomes. The European market is poised for further growth as healthcare systems adapt to meet rising demands.

Asia-Pacific : Rapidly Growing Nephrectomy Market

The Asia-Pacific nephrectomy market, valued at 550.0 million, is witnessing rapid growth driven by increasing healthcare investments and rising awareness of kidney health. The region's expanding population and urbanization contribute to a higher prevalence of kidney diseases, necessitating surgical interventions. Regulatory bodies are also promoting advanced surgical techniques, which are expected to boost market growth significantly. Countries like Japan, China, and India are leading the charge, with a competitive landscape that includes both local and international players such as Terumo Corporation. The market is characterized by a growing number of healthcare facilities and an increasing focus on minimally invasive procedures. As healthcare infrastructure improves, the Asia-Pacific region is set to become a key player in the nephrectomy market.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa nephrectomy market is valued at 109.7 million, reflecting a nascent but growing sector. Key growth drivers include increasing healthcare expenditure, rising awareness of kidney diseases, and the need for advanced surgical procedures. However, challenges such as limited access to healthcare facilities and varying regulatory environments can hinder market expansion. Efforts to improve healthcare infrastructure are crucial for future growth. Countries like South Africa and the UAE are leading the market, with a competitive landscape that includes both local and international players. The presence of key players such as Cook Medical is notable, as they contribute to the development of innovative surgical solutions. As the region continues to invest in healthcare, the nephrectomy market is expected to evolve and expand.

Key Players and Competitive Insights

The Nephrectomy Market is characterized by a dynamic competitive landscape, driven by advancements in surgical techniques and increasing prevalence of kidney diseases. Key players such as Medtronic (US), Johnson & Johnson (US), and Baxter International (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through the development of minimally invasive surgical technologies, while Johnson & Johnson (US) emphasizes strategic partnerships to expand its product offerings. Baxter International (US) is actively pursuing regional expansion, particularly in emerging markets, to capitalize on the growing demand for nephrectomy solutions. Collectively, these strategies contribute to a competitive environment that is increasingly shaped by technological advancements and collaborative efforts.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The Nephrectomy Market appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, catering to different patient needs and preferences. The collective influence of these major companies fosters a competitive structure that encourages innovation and responsiveness to market demands.

In November 2025, Medtronic (US) announced the launch of a new robotic-assisted surgical system designed specifically for nephrectomy procedures. This strategic move is significant as it positions Medtronic (US) to leverage the growing trend towards robotic surgery, potentially enhancing surgical precision and patient outcomes. The introduction of this technology may also serve to differentiate Medtronic (US) from competitors, reinforcing its commitment to innovation in surgical solutions.

In October 2025, Johnson & Johnson (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its nephrectomy product line. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Johnson & Johnson (US) is keen on enhancing patient engagement and post-operative care. By incorporating telehealth features, the company may improve patient outcomes and satisfaction, thereby strengthening its market position.

In September 2025, Baxter International (US) expanded its manufacturing capabilities in Asia, aiming to meet the rising demand for nephrectomy products in the region. This strategic expansion is crucial as it not only enhances Baxter's supply chain resilience but also positions the company to better serve a growing patient population in Asia. Such moves reflect a proactive approach to market dynamics, ensuring that Baxter remains competitive in a rapidly evolving landscape.

As of December 2025, current trends in the Nephrectomy Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into surgical practices. Strategic alliances are playing a pivotal role in shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the Nephrectomy Market.

Key Companies in the Nephrectomy Market market include

Industry Developments

The Americas accounts for the largest share in the global Market.

Future Outlook

Nephrectomy Market Future Outlook

<p>The Nephrectomy Market is projected to grow at a 7.39% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of kidney diseases, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of minimally invasive nephrectomy devices</p>
  • <p>Expansion of telehealth services for pre- and post-operative care</p>
  • <p>Investment in AI-driven surgical planning software</p>

<p>By 2035, the Nephrectomy Market is expected to achieve substantial growth and innovation.</p>

Market Segmentation

Nephrectomy Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Nephrectomy Market Indication Outlook

  • Renal Cell Carcinoma
  • Kidney Stones
  • Polycystic Kidney Disease
  • Trauma

Nephrectomy Market Procedure Type Outlook

  • Open Nephrectomy
  • Laparoscopic Nephrectomy
  • Robotic-Assisted Nephrectomy
  • Partial Nephrectomy

Nephrectomy Market Surgical Approach Outlook

  • Minimally Invasive Surgery
  • Traditional Surgery
  • Transplant Surgery

Nephrectomy Market Patient Demographics Outlook

  • Adult Patients
  • Pediatric Patients
  • Geriatric Patients

Report Scope

MARKET SIZE 20243315.7(USD Million)
MARKET SIZE 20253598.72(USD Million)
MARKET SIZE 20357295.26(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)7.39% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledMedtronic (US), Johnson & Johnson (US), Baxter International (US), Boston Scientific (US), Stryker (US), Terumo Corporation (JP), Fresenius Medical Care (DE), Smith & Nephew (GB), Cook Medical (US)
Segments CoveredProcedure Type, Indication, End User, Surgical Approach, Patient Demographics
Key Market OpportunitiesAdvancements in minimally invasive techniques enhance patient outcomes in the Nephrectomy Market.
Key Market DynamicsTechnological advancements and regulatory changes are reshaping the competitive landscape of the nephrectomy market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

At what CAGR is the nephrectomy market projected to grow in the forecast period (2023-2032)?

Nephrectomy market is projected grow at approximately 4.2% CAGR during the assessment period (2023-2032).

What was the value of the nephrectomy market in 2032?

The valuation of the nephrectomy market had reached USD 5.71 Billion in 2032.

Which is the major segment in the nephrectomy market?

The corticosteroid lotions segment by treatment type holds the majority shares in the nephrectomy market.

Which region holds the largest share in the nephrectomy market?

North America holds the largest share in the nephrectomy market, followed by Europe and the Asia Pacific, respectively.

Who are the top players in the nephrectomy market?

Olympus Corporation (Japan), KARL STORZ SE &amp; Co. KG (Germany)., Medtronic Plc (Ireland), Johnson &amp; Johnson Services Inc. (US), B. Braun Melsungen AG (Germany), Cook Group (US), XCELLANCE Medical Technologies (India), and CONMED Corporation (US), are some of the major players operating in the global nephrectomy market.

Which region holds the latest share in the Nephrectomy Market?

North America holds the largest share in the Nephrectomy Market, which is followed by Europe and the Asia Pacific respectively.

  1. EXECUTIVE SUMMARY
  2. MARKET INTRODUCTION
    1. DEFINITION 13
    2. SCOPE OF THE STUDY 13
    3. RESEARCH OBJECTIVE 13
    4. MARKET STRUCTURE 14
  3. RESEARCH METHODOLOGY
    1. RESEARCH PROCESS 15
    2. PRIMARY RESEARCH 16
    3. SECONDARY RESEARCH 17
    4. MARKET SIZE ESTIMATION 18
    5. FORECAST MODEL 19
    6. LIST OF ASSUMPTIONS 20
  4. MARKET DYNAMICS
    1. INTRODUCTION 21
    2. DRIVERS 22
      1. INCREASING PREVALENCE OF KIDNEY CANCER AND CHRONIC KIDNEY DISEASES 22
      2. RISING NUMBER OF LAPAROSCOPIC NEPHRECTOMY PROCEDURES 22
      3. INCREASING AWARENESS AND DEMAND FOR ORGAN (KIDNEY) TRANSPLANT 22
      4. DRIVERS IMPACT ANALYSIS 23
    3. RESTRAINTS 24
      1. RISKS AND COMPLICATIONS OF THE NEPHRECTOMY SURGERY 24
      2. HIGH COST RELATED OF THE PROCEDURE 24
      3. RESTRAINTS IMPACT ANALYSIS 24
    4. OPPORTUNITIES 25
      1. TECHNOLOGICAL ADVANCEMENTS IN LAPAROSCOPY NEPHRECTOMY 25
  5. MARKET FACTOR ANALYSIS
    1. PORTER’S FIVE FORCES MODEL 26
      1. BARGAINING POWER OF SUPPLIERS 26
      2. BARGAINING POWER OF BUYERS 26
      3. THREAT OF NEW ENTRANTS 27
      4. THREAT OF SUBSTITUTES 27
      5. INTENSITY OF RIVALRY 27
    2. VALUE CHAIN ANALYSIS 28
      1. R&D AND DESIGNING 29
      2. MANUFACTURING 29
      3. DISTRIBUTION 29
      4. MARKETING & SALES 29
      5. POST-SALES MONITORING 29
    3. PRICING ANALYSIS 30
  6. NEPHRECTOMY MARKET, BY PROCEDURE
    1. OVERVIEW 31
    2. LAPAROSCOPIC NEPHRECTOMY 32
    3. ROBOT-ASSISTED LAPAROSCOPIC NEPHRECTOMY 33
    4. OPEN NEPHRECTOMY 33
  7. NEPHRECTOMY MARKET, BY INDICATION
    1. OVERVIEW 34
    2. KIDNEY CANCER 35
    3. OTHER KIDNEY DISEASES 36
  8. NEPHRECTOMY MARKET, BY END USER
    1. OVERVIEW 37
    2. HOSPITALS & CLINICS 38
    3. SURGICAL CENTERS 38
  9. GLOBAL NEPHRECTOMY MARKET, BY REGION
    1. OVERVIEW 39
    2. AMERICAS 41
  10. NEPHRECTOMY MARKET, BY PROCEDURE
  11. NEPHRECTOMY MARKET, BY INDICATION
  12. NEPHRECTOMY MARKET, BY END USER
  13. NORTH AMERICA 42
  14. NEPHRECTOMY MARKET, BY PROCEDURE
  15. NEPHRECTOMY MARKET, BY INDICATION
  16. NEPHRECTOMY MARKET, BY END USER
  17. US 44
  18. NEPHRECTOMY MARKET, BY PROCEDURE
  19. NEPHRECTOMY MARKET, BY INDICATION
  20. NEPHRECTOMY MARKET, BY END USER
  21. CANADA 45
  22. NEPHRECTOMY MARKET, BY PROCEDURE
  23. NEPHRECTOMY MARKET, BY INDICATION
  24. NEPHRECTOMY MARKET, BY END USER
  25. LATIN AMERICA 46
  26. NEPHRECTOMY MARKET, BY PROCEDURE
  27. NEPHRECTOMY MARKET, BY INDICATION
  28. NEPHRECTOMY MARKET, BY END USER
    1. EUROPE 48
  29. NEPHRECTOMY MARKET, BY PROCEDURE
  30. NEPHRECTOMY MARKET, BY INDICATION
  31. NEPHRECTOMY MARKET, BY END USER
  32. WESTERN EUROPE 49
  33. NEPHRECTOMY MARKET, BY PROCEDURE
  34. NEPHRECTOMY MARKET, BY INDICATION
  35. NEPHRECTOMY MARKET, BY END USER
  36. GERMANY 51
  37. NEPHRECTOMY MARKET, BY PROCEDURE
  38. NEPHRECTOMY MARKET, BY INDICATION
  39. NEPHRECTOMY MARKET, BY END USER
  40. FRANCE 52
  41. NEPHRECTOMY MARKET, BY PROCEDURE
  42. NEPHRECTOMY MARKET, BY INDICATION
  43. NEPHRECTOMY MARKET, BY END USER
  44. UK 53
  45. NEPHRECTOMY MARKET, BY PROCEDURE
  46. NEPHRECTOMY MARKET, BY INDICATION
  47. NEPHRECTOMY MARKET, BY END USER
  48. ITALY 54
  49. NEPHRECTOMY MARKET, BY PROCEDURE
  50. NEPHRECTOMY MARKET, BY INDICATION
  51. NEPHRECTOMY MARKET, BY END USER
  52. SPAIN 55
  53. NEPHRECTOMY MARKET, BY PROCEDURE
  54. NEPHRECTOMY MARKET, BY INDICATION
  55. NEPHRECTOMY MARKET, BY END USER
  56. REST OF WESTERN EUROPE 56
  57. NEPHRECTOMY MARKET, BY PROCEDURE
  58. NEPHRECTOMY MARKET, BY INDICATION
  59. NEPHRECTOMY MARKET, BY END USER
  60. EASTERN EUROPE 57
  61. NEPHRECTOMY MARKET, BY PROCEDURE
  62. NEPHRECTOMY MARKET, BY INDICATION
  63. NEPHRECTOMY MARKET, BY END USER
    1. ASIA-PACIFIC 58
  64. NEPHRECTOMY MARKET, BY PROCEDURE
  65. NEPHRECTOMY MARKET, BY INDICATION
  66. NEPHRECTOMY MARKET, BY END USER
  67. CHINA 60
  68. NEPHRECTOMY MARKET, BY PROCEDURE
  69. NEPHRECTOMY MARKET, BY INDICATION
  70. NEPHRECTOMY MARKET, BY END USER
  71. INDIA 61
  72. NEPHRECTOMY MARKET, BY PROCEDURE
  73. NEPHRECTOMY MARKET, BY INDICATION
  74. NEPHRECTOMY MARKET, BY END USER
  75. JAPAN 62
  76. NEPHRECTOMY MARKET, BY PROCEDURE
  77. NEPHRECTOMY MARKET, BY INDICATION
  78. NEPHRECTOMY MARKET, BY END USER
  79. AUSTRALIA 63
  80. NEPHRECTOMY MARKET, BY PROCEDURE
  81. NEPHRECTOMY MARKET, BY INDICATION
  82. NEPHRECTOMY MARKET, BY END USER
  83. SOUTH KOREA 64
  84. NEPHRECTOMY MARKET, BY PROCEDURE
  85. NEPHRECTOMY MARKET, BY INDICATION
  86. NEPHRECTOMY MARKET, BY END USER
  87. REST OF ASIA-PACIFIC 65
  88. NEPHRECTOMY MARKET, BY PROCEDURE
  89. NEPHRECTOMY MARKET, BY INDICATION
  90. NEPHRECTOMY MARKET, BY END USER
    1. REST OF THE WORLD (ROW) 66
  91. NEPHRECTOMY MARKET, BY PROCEDURE
  92. NEPHRECTOMY MARKET, BY INDICATION
  93. NEPHRECTOMY MARKET, BY END USER
  94. COMPETITIVE LANSCAPE 67
  95. NEPHRECTOMY MARKET, BY PROCEDURE
  96. NEPHRECTOMY MARKET, BY INDICATION
  97. NEPHRECTOMY MARKET, BY END USER
    1. OVERVIEW 67
  98. COMPANY PROFILES
    1. KARL STORZ SE & CO. KG 68
      1. COMPANY OVERVIEW 68
      2. FINANCIAL OVERVIEW 68
      3. PRODUCTS/SERVICES OFFERED 68
      4. KEY DEVELOPMENTS 68
      5. SWOT ANALYSIS 69
      6. KEY STRATEGIES 69
    2. OLYMPUS CORPORATION 70
      1. COMPANY OVERVIEW 70
      2. FINANCIAL OVERVIEW 70
      3. PRODUCTS/SERVICES OFFERED 71
      4. KEY DEVELOPMENTS 71
      5. SWOT ANALYSIS 72
      6. KEY STRATEGIES 72
    3. MEDTRONIC 73
      1. COMPANY OVERVIEW 73
      2. FINANCIAL OVERVIEW 73
      3. PRODUCTS/SERVICES OFFERED 74
      4. KEY DEVELOPMENTS 74
      5. SWOT ANALYSIS 75
      6. KEY STRATEGIES 75
    4. B. BRAUN MELSUNGEN AG 76
      1. COMPANY OVERVIEW 76
      2. FINANCIAL OVERVIEW 76
      3. PRODUCTS/SERVICES OFFERED 77
      4. KEY DEVELOPMENTS 77
      5. SWOT ANALYSIS 78
      6. KEY STRATEGIES 78
    5. JOHNSON & JOHNSON SERVICES, INC. 79
      1. COMPANY OVERVIEW 79
      2. FINANCIAL OVERVIEW 79
      3. PRODUCTS/SERVICES OFFERED 80
      4. KEY DEVELOPMENTS 80
      5. SWOT ANALYSIS 81
      6. KEY STRATEGIES 81
    6. COOK GROUP 82
      1. COMPANY OVERVIEW 82
      2. FINANCIAL OVERVIEW 82
      3. PRODUCTS/SERVICES OFFERED 82
      4. KEY DEVELOPMENTS 82
      5. SWOT ANALYSIS 83
      6. KEY STRATEGIES 83
    7. CONMED CORPORATION 84
      1. COMPANY OVERVIEW 84
      2. FINANCIAL OVERVIEW 84
      3. PRODUCTS/SERVICES OFFERED 85
      4. KEY DEVELOPMENTS 85
      5. SWOT ANALYSIS 86
      6. KEY STRATEGIES 86
    8. XCELLANCE MEDICAL TECHNOLOGIES 87
      1. COMPANY OVERVIEW 87
      2. FINANCIAL OVERVIEW 87
      3. PRODUCTS/SERVICES OFFERED 87
      4. KEY DEVELOPMENTS 87
      5. SWOT ANALYSIS 88
      6. KEY STRATEGIES 88
  99. APPENDIX
    1. REFERENCES 89
    2. RELATED REPORTS 89
  100. LIST OF TABLES
  101. PRIMARY INTERVIEWS 16
  102. LIST OF ASSUMPTIONS 20
  103. GLOBAL NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 31
  104. GLOBAL NEPHRECTOMY MARKET FOR LAPAROSCOPIC NEPHRECTOMY, BY REGION 2020–2027 (USD MILLION) 32
  105. GLOBAL NEPHRECTOMY MARKET FOR ROBOT-ASSISTED LAPAROSCOPIC NEPHRECTOMY, BY REGION 2020–2027
    1. (USD MILLION) 33
  106. GLOBAL NEPHRECTOMY MARKET FOR OPEN NEPHRECTOMY, BY REGION 2020–2027 (USD MILLION) 33
  107. GLOBAL NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 34
  108. GLOBAL NEPHRECTOMY MARKET FOR KIDNEY CANCER, BY REGION 2020–2027 (USD MILLION) 35
  109. GLOBAL NEPHRECTOMY MARKET FOR OTHER KIDNEY DISEASES, BY REGION 2020–2027 (USD MILLION) 36
  110. GLOBAL NEPHRECTOMY MARKET, BY END USER, 2020–2027 (USD MILLION) 37
  111. GLOBAL NEPHRECTOMY MARKET FOR HOSPITALS & CLINICS, BY REGION 2020–2027 (USD MILLION) 38
  112. GLOBAL NEPHRECTOMY MARKET FOR SURGICAL CENTERS, BY REGION 2020–2027 (USD MILLION) 38
  113. GLOBAL NEPHRECTOMY MARKET, BY REGION, 2020–2027 (USD MILLION) 39
  114. AMERICAS: NEPHRECTOMY MARKET, BY REGION, 2020–2027 (USD MILLION) 41
  115. AMERICAS: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 41
  116. AMERICAS: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 42
  117. AMERICAS: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 42
  118. AMERICAS: NEPHRECTOMY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 42
  119. NORTH AMERICA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 43
  120. NORTH AMERICA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 43
  121. NORTH AMERICA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 44
  122. US: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 44
  123. US: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 44
  124. US: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 45
  125. CANADA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 45
  126. CANADA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 45
  127. CANADA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 46
  128. LATIN AMERICA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 46
  129. LATIN AMERICA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 46
  130. LATIN AMERICA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 47
  131. EUROPE: NEPHRECTOMY MARKET, BY REGION, 2020–2027 (USD MILLION) 48
  132. EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 48
  133. EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 49
  134. EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 49
  135. WESTERN EUROPE: NEPHRECTOMY MARKET, BY COUNTRY/REGION, 2020–2027 (USD MILLION) 49
  136. WESTERN EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 50
  137. WESTERN EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 50
  138. WESTERN EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 51
  139. GERMANY: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 51
  140. GERMANY: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 51
  141. GERMANY: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 52
  142. FRANCE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 52
  143. FRANCE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 52
  144. FRANCE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 53
  145. UK: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 53
  146. UK: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 53
  147. UK: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 54
  148. ITALY: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 54
  149. ITALY: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 54
  150. ITALY: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 55
  151. SPAIN: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 55
  152. SPAIN: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 55
  153. SPAIN: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 56
  154. REST OF WESTERN EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 56
  155. REST OF WESTERN EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 56
  156. REST OF WESTERN EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 57
  157. EASTERN EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 57
  158. EASTERN EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 57
  159. EASTERN EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 58
  160. ASIA-PACIFIC: NEPHRECTOMY MARKET, BY COUNTRY/REGION, 2020–2027 (USD MILLION) 58
  161. ASIA PACIFIC: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 59
  162. ASIA PACIFIC: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 59
  163. ASIA PACIFIC: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 59
  164. CHINA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 60
  165. CHINA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 60
  166. CHINA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 60
  167. INDIA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 61
    1. TABLE 68

Nephrectomy Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓